Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Bristol-Myers' Cancer Drug Could Push the Stock 25% Higher

Barron's - 13 Feb 2016 09:03
Bristol-Myers' Cancer Drug Could Push the Stock 25% Higher Cancer drug Opdivo has won FDA approval--potentially $8 billion-$9 billion in annual sales.
Full Article at Barron's

More Business News
9
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard